Key result
Myocardial triglyceride content was significantly lower in hypertrophic cardiomyopathy patients with late gadolinium enhancement compared to those without (0.58% vs 1.29%, P=0.03).
Why the study?
The difference between myocardial metabolism and myocardial features such as myocardial fibrosis and myofiber disarray in hypertrophic cardiomyopathy remains unclear.
Does the presence of late gadolinium enhancement correlate with differences in myocardial triglyceride content and LV function in patients with hypertrophic cardiomyopathy and asymmetric septal hypertrophy?
Cross-Sectional (n=16)
No
Does the presence of late gadolinium enhancement correlate with differences in myocardial triglyceride content and LV function in patients with hypertrophic cardiomyopathy and asymmetric septal hypertrophy?
Absolute Event Rate: 0.58% vs 1.29%
p-value: p=0.03
In patients with hypertrophic cardiomyopathy and asymmetric septal hypertrophy, the presence of late gadolinium enhancement is associated with lower myocardial triglyceride content and reduced LV ejection fraction.
Asymmetric septal hypertrophy (ASH) is the most common phenotype of hypertrophic cardiomyopathy (HCM). However, the difference between myocardial metabolism and myocardial features such as myocardial fibrosis and myofiber disarray in HCM remains unclear. Cardiac magnetic resonance (CMR) and proton magnetic resonance spectroscopy ( 1 H-MRS) were performed on 16 patients diagnosed as HCM with ASH to assess the differences in myocardial features and morphology. There were 7 patients who had LGE in ASH localized with the voxel of 1 H-MRS. The LV ejection fraction was significantly lower in the LGE (+) group than in the LGE (−) group (64.8% ± 4.9% vs. 72.1% ± 3.8%, P = 0.004). LV end-systolic volume was significantly greater in the LGE (+) group than in the LGE (−) group (51 ± 11 ml vs. 33 ± 12 ml, P = 0.007). A significant difference in MTG content was observed between patients in the LGE (+) group and in the LGE (−) group (0.58% ± 0.22% vs 1.29% ± 0.73%, P = 0.03). MTG content was significantly associated with LV ejection fraction, LV end systolic volume, and LV mass. In multivariate analyses, LV ejection fraction had an independent association with MTG content (P = 0.01) Our data suggest that the metabolism of the septum in HCM with ASH may be different based on the absence or presence of LGE and that measurement of MTG content by 1 H-MRS may be useful to evaluate the characteristics of myocardial metabolic changes caused by the LV remodeling process in HCM. (248 words)
No takes yet. Share an insight, caveat, or question.
Sai et al. (2022) conducted a cross-sectional in Hypertrophic Cardiomyopathy with Asymmetric Septal Hypertrophy (n=16). Late gadolinium enhancement (LGE) vs. Absence of late gadolinium enhancement was evaluated on Myocardial triglyceride (MTG) content (p=0.03). Myocardial triglyceride content was significantly lower in hypertrophic cardiomyopathy patients with late gadolinium enhancement compared to those without (0.58% vs 1.29%, P=0.03).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: